Perioperative High-dose Rate Brachytherapy Using a Bendy Applicator (Flab): Treatment Results of 74 Patients

Background: Radiotherapy plays a pivotal role in tumor treatment. Brachytherapy as an additional radiation technique allows local dose increments in areas at high risk of local failure. Patients and Methods: Our past 15-year experience with tissue-equivalent bendy applicator brachytherapy at the Uni...

Full description

Saved in:
Bibliographic Details
Published in:Anticancer research Vol. 28; no. 6B; pp. 3885 - 3890
Main Authors: BÖPOLLING, Tobias, SCHÜLLER, Patrick, WILLICH, Normann, KÖNEMANN, Stefan, DISTELMAIER, Bernd, SCHUCK, Andreas, ERNST, Iris, GOSHEGER, Georg, WINKELMANN, Winfried, DIRKSEN, Uta, JÜRGENS, Heribert, KRONHOLZ, Hans-Lars
Format: Journal Article
Language:English
Published: Attiki International Institute of Anticancer Research 01-11-2008
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background: Radiotherapy plays a pivotal role in tumor treatment. Brachytherapy as an additional radiation technique allows local dose increments in areas at high risk of local failure. Patients and Methods: Our past 15-year experience with tissue-equivalent bendy applicator brachytherapy at the University Hospital Münster, Germany was reviewed. A series of 74 consecutive patients who had mainly been treated for sarcomas with perioperative brachytherapy was analyzed with a focus on local relapse-free survival and side-effects. Results: The 5-year local control rate was 73% in primary treatment situations with a significant influence of additional external irradiation, surgical margin depth and tumor entity. Late sequelae of combined modality treatment were observed in 40 patients (54%) and mainly concerned wound healing (n=18, 24%). Conclusion: A high-risk collective, in view of local failure, showed adequate local control rates as well as acceptable late sequelae. Flab brachytherapy is a good treatment option to achieve local radiation dose increments in patients at high risk of local failure.
ISSN:0250-7005
1791-7530